ARTICLE | Financial News
Kolltan withdraws IPO
January 29, 2015 1:39 AM UTC
Cancer play Kolltan Pharmaceuticals Inc. (New Haven, Conn.) withdrew its proposed IPO on NASDAQ. The company did not provide a reason in its SEC filing and did not respond to inquiries. In September, Kolltan filed to raise up to $86.3 million in an offering underwritten by Leerink Partners; Stifel; Guggenheim Securities; and Janney Montgomery Scott. ...